These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

170 related articles for article (PubMed ID: 1279609)

  • 1. Atrial fibrillation in Wolff-Parkinson-White syndrome: reversal of isoproterenol effects by sotalol.
    Madrid AH; Moro C; Maŕin Huerta EM; Novo L; Mestre JL
    Pacing Clin Electrophysiol; 1992 Nov; 15(11 Pt 2):2111-5. PubMed ID: 1279609
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Effect of flestolol on ventricular rate during atrial fibrillation in Wolff-Parkinson-White syndrome.
    Swerdlow CD; Peterson J; Liem LB
    Am J Cardiol; 1988 Jul; 62(1):78-82. PubMed ID: 2898208
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Comparison of the ventricular response during atrial fibrillation in patients with enhanced atrioventricular node conduction and Wolff-Parkinson-White syndrome.
    Milstein S; Klein GJ; Rattes MF; Sharma AD; Yee R
    J Am Coll Cardiol; 1987 Dec; 10(6):1244-8. PubMed ID: 3680792
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Sotalol in the Wolff-Parkinson-White syndrome: an electrophysiological and clinical study].
    Inama G; Furlanello F; Vergara G; Guarnerio M; Braito G; Nassivera E
    G Ital Cardiol; 1992 Jun; 22(6):701-13. PubMed ID: 1426808
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Sotalol in supraventricular tachycardia. Electrophysiologic measurements in Wolff-Parkinson-White syndrome and AV node re-entry tachycardia].
    Manz M; Kuhl AJ; Lüderitz B
    Z Kardiol; 1985 Sep; 74(9):500-5. PubMed ID: 4060827
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Effects of exercise and isoproterenol during atrial fibrillation in patients with Wolff-Parkinson-White syndrome.
    German LD; Gallagher JJ; Broughton A; Guarnieri T; Trantham JL
    Am J Cardiol; 1983 Apr; 51(7):1203-6. PubMed ID: 6837463
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Effect of propranolol on ventricular rate during atrial fibrillation in the Wolff-Parkinson-White syndrome.
    Morady F; DiCarlo LA; Baerman JM; De Buitleir M
    Pacing Clin Electrophysiol; 1987 May; 10(3 Pt 1):492-6. PubMed ID: 2439997
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Effects of oral sotalol on the conduction of accessory atrioventricular pathways].
    Blanc JJ; Boschat J; Ollivier JP; Penther P
    Arch Mal Coeur Vaiss; 1985 Jul; 78(7):1097-102. PubMed ID: 3929739
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Usefulness of isoproterenol during atrial fibrillation in evaluation of asymptomatic Wolff-Parkinson-White pattern.
    Szabo TS; Klein GJ; Sharma AD; Yee R; Milstein S
    Am J Cardiol; 1989 Jan; 63(3):187-92. PubMed ID: 2909998
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Linking: a mechanism of intermittent preexcitation in the Wolff-Parkinson-White syndrome.
    Middlekauff HR; Stevenson WG; Klitzner TS
    Pacing Clin Electrophysiol; 1990 Dec; 13(12 Pt 1):1629-36. PubMed ID: 1704516
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Electrophysiologic effect of sotalol in supraventricular tachycardias].
    Borggrefe M; Breithardt G
    Z Kardiol; 1985 Sep; 74(9):506-11. PubMed ID: 4060828
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Electropharmacology of sotalol in patients with Wolff-Parkinson-White syndrome.
    Mitchell LB; Wyse DG; Duff HJ
    Circulation; 1987 Oct; 76(4):810-8. PubMed ID: 2820614
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Influence of exercise on the permeability of accessory pathways and supraventricular arrhythmia in Wolff-Parkinson-White syndrome].
    Mabo P; Kermarrec A; Gras D; Paillard F; Bédossa M; Daubert C
    Arch Mal Coeur Vaiss; 1992 Oct; 85(10):1443-8. PubMed ID: 1297293
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Electrophysiologic effects of lorcainide on the accessory pathway in the Wolff-Parkinson-White syndrome.
    Kasper W; Treese N; Meinertz T; Jähnchen E; Pop T
    Am J Cardiol; 1983 Jun; 51(10):1618-22. PubMed ID: 6858867
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Electrophysiologic effects of oral propafenone in Wolff-Parkinson-White syndrome studied by programmed electrical stimulation.
    Sethi KK; Prasad GS; Mohan JC; Arora R; Khalilullah M
    Indian Heart J; 1991; 43(1):5-10. PubMed ID: 1894303
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Effects of isoproterenol on accessory pathway conduction in intermittent or concealed Wolff-Parkinson-White syndrome.
    Yamamoto T; Yeh SJ; Lin FC; Wu DL
    Am J Cardiol; 1990 Jun; 65(22):1438-42. PubMed ID: 2353648
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Susceptibility to atrial fibrillation and ventricular tachyarrhythmia in the Wolff-Parkinson-White syndrome: role of the accessory pathway.
    Waspe LE; Brodman R; Kim SG; Fisher JD
    Am Heart J; 1986 Dec; 112(6):1141-52. PubMed ID: 3788760
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Longitudinal clinical and electrophysiological assessment of patients with symptomatic Wolff-Parkinson-White syndrome and atrioventricular node reentrant tachycardia.
    Chen SA; Chiang CE; Tai CT; Lee SH; Chiou CW; Ueng KC; Wen ZC; Cheng CC; Chang MS
    Circulation; 1996 Jun; 93(11):2023-32. PubMed ID: 8640978
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Conduction over an isthmus of atrial myocardium in vivo: a possible model of Wolff-Parkinson-White syndrome.
    Inoue H; Zipes DP
    Circulation; 1987 Sep; 76(3):637-47. PubMed ID: 3621524
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Efficacy of amiodarone in the Wolff-Parkinson-White syndrome with rapid ventricular response via accessory pathway during atrial fibrillation.
    Kappenberger LJ; Fromer MA; Steinbrunn W; Shenasa M
    Am J Cardiol; 1984 Aug; 54(3):330-5. PubMed ID: 6465013
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.